Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Rosell

Showing results (51-60 of 565) with videos related to

Pageof 57
Sort By:
Journal of Thoracic Disease|May 25, 2026
Chemotherapy in combination with KRAS inhibitors in <i>KRAS</i>-mutated non-small cell lung cancerRafael Rosell, María González-Cao
The Lancet. Oncology|October 9, 2019
Are neutralising anti-VEGF or VEGFR2 antibodies necessary in the treatment of EGFR-mutated non-small-cell lung cancer?Rafael Rosell, Carlos Pedraz-Valdunciel
Journal of Thoracic Disease|April 30, 2015
Second-line treatment in EGFR-unselected patients: is it time to close one arm of this river's DELTA?Daniela Morales-Espinosa, Rafael Rosell
The Lancet Regional Health. Europe|September 5, 2022
Ablating lung cancer, knowing the tumor betterRafael Rosell, María González-Cao
JTO Clinical and Research Reports|October 16, 2023
Lung Cancer Organoids as Avatars of Patients With Lung Cancer in the Prediction of Therapeutic ResponseRafael Rosell, Carlos Pedraz-Valdunciel
Lung Cancer (Amsterdam, Netherlands)|February 9, 2005
Neoadjuvant treatment of early-stage resectable non-small-cell lung cancerDaniel C Betticher, Rafael Rosell
Nature Reviews. Clinical Oncology|December 6, 2023
Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamabRafael Rosell, María González-Cao
Lancet (London, England)|February 14, 2021
Cemiplimab monotherapy in advanced non-squamous and squamous non-small cell lung cancerRafael Rosell, Maria Gonzalez-Cao
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2007
Weighing tumor biology in treatment decisions for patients with non-small cell lung cancerFrances A Shepherd, Rafael Rosell
Translational Lung Cancer Research|January 23, 2016
Cancer stem cells and immunoresistance: clinical implications and solutionsJordi Codony-Servat, Rafael Rosell
Pageof 57

Showing results (51-60 of 565) with videos related to

Sort By:
Pageof 57
Journal of Thoracic Disease|May 25, 2026
Chemotherapy in combination with KRAS inhibitors in <i>KRAS</i>-mutated non-small cell lung cancerRafael Rosell, María González-Cao
The Lancet. Oncology|October 9, 2019
Are neutralising anti-VEGF or VEGFR2 antibodies necessary in the treatment of EGFR-mutated non-small-cell lung cancer?Rafael Rosell, Carlos Pedraz-Valdunciel
Journal of Thoracic Disease|April 30, 2015
Second-line treatment in EGFR-unselected patients: is it time to close one arm of this river's DELTA?Daniela Morales-Espinosa, Rafael Rosell
The Lancet Regional Health. Europe|September 5, 2022
Ablating lung cancer, knowing the tumor betterRafael Rosell, María González-Cao
JTO Clinical and Research Reports|October 16, 2023
Lung Cancer Organoids as Avatars of Patients With Lung Cancer in the Prediction of Therapeutic ResponseRafael Rosell, Carlos Pedraz-Valdunciel
Lung Cancer (Amsterdam, Netherlands)|February 9, 2005
Neoadjuvant treatment of early-stage resectable non-small-cell lung cancerDaniel C Betticher, Rafael Rosell
Nature Reviews. Clinical Oncology|December 6, 2023
Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamabRafael Rosell, María González-Cao
Lancet (London, England)|February 14, 2021
Cemiplimab monotherapy in advanced non-squamous and squamous non-small cell lung cancerRafael Rosell, Maria Gonzalez-Cao
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 13, 2007
Weighing tumor biology in treatment decisions for patients with non-small cell lung cancerFrances A Shepherd, Rafael Rosell
Translational Lung Cancer Research|January 23, 2016
Cancer stem cells and immunoresistance: clinical implications and solutionsJordi Codony-Servat, Rafael Rosell
Pageof 57